Skip to main content

Table 2 Characteristics of studies included in the review

From: Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis

Study

N

Study period (years)

Disease Stage

Histology

Male

Median Age (years)

I

II

squamous

adeno

large-cell

(a) Cohort studies

Raz 2007

1432

13

1432

NR

460

419

89

747

74

Wisnivesky 2007a

2344

8

NR

NR

NR

NR

NR

1292

NR

Chadha 2005

39

11

23

13

18

88

5

4

77

Henschke 2003

131

7

131

NR

NR

NR

NR

NR

NR

McGarry 2002a

49

5

NR

NR

NR

NR

NR

49

NR

Vrdoljak 1994

130

7

55

56

61

35

34

120

60

Hyde 1973

293

8

NR

NR

NR

NR

NR

NR

NR

Total/(Range)

4418

(5 to 13)

1641

68

539

542

128

2211

 

(b) RCTs

  

III

IV

     

Goss 2009c

101

2 (0.23)

17

84

25

46

11

61

76

Anderson 2000

150

2

92

58

NR

NR

NR

91

64

ELVIS 1999c

78

1 (1.08)

22

56

33

29

3

69

74b

Cullen 1999c

176

8 (2.17)

88

88

103

42

6

122

64

Thongprasert 1999

98

4

49

49

31

49

12

NR

60

Helsing 1998c

26

5 (3.33)

3

23

5

17

4

18

65

Cartei 1993

50

7

NR

50

25

17

8

36

57

Leung 1992c

66

4 (3.58)

58

NR

31

18

7

48

62

Cellerino 1991

61

3

61

NR

38

18

5

59

62

Quoix 1991

22

3

NR

22

NR

NR

NR

NR

NR

Kaasa 1991

43

3

NR

43

16

16

11

31

62b

Ganz 1989

26

2

NR

26

9

17

NR

23

NR

Rapp 1988

50

3

50

NR

12

24

12

38

58

Cormier 1982

17

2

17

NR

8

2

6

16

60

Laing 1975

67

2

15

20

23

5

9

59

64

Total/(Range)

1031

(1 to 8)

472

519

359

300

94

671

(57 to 76)

  1. N = Sample size or number of participants enrolled; NR = data not reported; adeno, = adenocarcinoma; squamous, = squamous cell carcinoma; large-cell, = large-cell carcinoma; asample includes stage I and II cancer; brecorded mean age where median age was not reported or not extractable, cmedian follow-up in parenthesis.